2009-2013年邳州市手足口病流行病学特征分析

来源 :中国校医 | 被引量 : 0次 | 上传用户:limiao912
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的了解手足口病在邳州市的流行病学和病原学特征,为制定手足口病防控策略提供科学依据。方法对邳州市2009—2013年手足口病发病资料采用描述流行病学方法进行统计和分析。结果 2009—2013年全市共报告手足口病病例2 601例,年平均发病率29.29/10万。发病高峰为4—7月,占病例报告总数的71.90%。男女性别比为1.96∶1,发病年龄主要为5岁以下儿童,占病例报告总数的97.81%,其中又以3岁以下婴幼儿发病率为最高。职业以散居儿童为主,占92.50%。5年内引起邳州市手足口病流行的主要病原体为肠道病毒71型,占病原学检测阳性数的79.76%。结论手足口病发病具有明显的性别、年龄和季节性差异,应加强病原学监测和重点人群的防控。 Objective To understand the epidemiological and etiological characteristics of hand-foot-mouth disease in Danzhou and provide a scientific basis for the prevention and control of hand-foot-mouth disease. Methods The epidemiological data of hand-foot-mouth disease in Zhuozhou from 2009 to 2013 were collected for statistical analysis. Results A total of 2 601 HFMD cases were reported in the city from 2009 to 2013, with an average annual incidence of 29.29 / 100 000. The peak incidence was from April to July, accounting for 71.90% of the total number of case reports. The male-to-female sex ratio was 1.96: 1, and the main age of onset was children under 5 years old, accounting for 97.81% of the total number of case reports. Among them, the incidence of infants and young children under 3 was the highest. Occupation of scattered children, accounting for 92.50%. The main pathogen that caused the epidemic of hand, foot and mouth disease in Pizhou in 5 years was enterovirus 71, accounting for 79.76% of the positive number of pathogen detection. Conclusion The incidence of hand, foot and mouth disease has obvious gender, age and seasonal differences. Etiological monitoring should be strengthened and prevention and control of key populations should be strengthened.
其他文献
2007年12月,巩义市作为河南省首批新农村电气化建设试点县之一,顺利通过河南省电力公司和河南省发改委组织的考评验收.在新农村电气化建设过程中.巩义市供电公司坚持“政府主
期刊
随着医疗技术的发展,血管介入性导管技术广泛应用于临床,为患者进行输液、营养支持、血液滤过以及血流动力学监测等,但随之而来的中心静脉导管相关感染(CVC-RI)也越来越多,成
期刊
【目的】通过对玉米幼胚培养,建立~套稳定性好、再生率高的组织培养体系。【方法】以4个玉米自交系幼胚为外植体,研究不同基因型、幼胚大小、2,4-D浓度、AgNO_3浓度对愈伤组织
期刊
期刊
期刊
目的讨Y染色体微缺失基因检测的临床意义。方法应用4组多重PCR技术对147例不孕患者进行Y染色体AZF基因家族AZFa、AZFb、AZFc、AZFd 4个座位上15个STS位点和1个内控位点的检测
目的观察恩替卡韦治疗失代偿期乙型肝炎肝硬化疗效和安全性。方法49例失代偿期乙肝肝硬化患者(Child-PughB级35例,C级14例)随机分为两组,治疗组28例,恩替卡韦0.5 mg,1次/d口